These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 29377650

  • 1. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage.
    Broekgaarden M, Weijer R, van Wijk AC, Cox RC, Egmond MR, Hoebe R, van Gulik TM, Heger M.
    J Biomed Nanotechnol; 2017 Feb; 13(2):204-20. PubMed ID: 29377650
    [Abstract] [Full Text] [Related]

  • 2. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
    Dias LM, Sharifi F, de Keijzer MJ, Mesquita B, Desclos E, Kochan JA, de Klerk DJ, Ernst D, de Haan LR, Franchi LP, van Wijk AC, Scutigliani EM, Cavaco JEB, Tedesco AC, Huang X, Pan W, Ding B, Krawczyk PM, Heger M, Photodynamic Therapy Study Group.
    J Photochem Photobiol B; 2021 Mar; 216():112146. PubMed ID: 33601256
    [Abstract] [Full Text] [Related]

  • 3. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
    Broekgaarden M, de Kroon AI, Gulik TM, Heger M.
    Curr Med Chem; 2014 Mar; 21(3):377-91. PubMed ID: 23931271
    [Abstract] [Full Text] [Related]

  • 4. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y, Yang X, Li H, Li C, Ding H, Zhang M, Guo Y, Sun M.
    Colloids Surf B Biointerfaces; 2019 Jan 01; 173():564-570. PubMed ID: 30347383
    [Abstract] [Full Text] [Related]

  • 5. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer.
    Kuzyniak W, Schmidt J, Glac W, Berkholz J, Steinemann G, Hoffmann B, Ermilov EA, Gürek AG, Ahsen V, Nitzsche B, Höpfner M.
    Int J Oncol; 2017 Mar 01; 50(3):953-963. PubMed ID: 28098886
    [Abstract] [Full Text] [Related]

  • 6. Low-power photodynamic therapy induces survival signaling in perihilar cholangiocarcinoma cells.
    Weijer R, Broekgaarden M, van Golen RF, Bulle E, Nieuwenhuis E, Jongejan A, Moerland PD, van Kampen AH, van Gulik TM, Heger M.
    BMC Cancer; 2015 Dec 26; 15():1014. PubMed ID: 26705830
    [Abstract] [Full Text] [Related]

  • 7. A Nanoencapsulated Ir(III)-Phthalocyanine Conjugate as a Promising Photodynamic Therapy Anticancer Agent.
    Bonelli J, Ortega-Forte E, Vigueras G, Follana-Berná J, Ashoo P, Abad-Montero D, Isidro N, López-Corrales M, Hernández A, Ortiz J, Izquierdo-García E, Bosch M, Rocas J, Sastre-Santos Á, Ruiz J, Marchán V.
    ACS Appl Mater Interfaces; 2024 Jul 31; 16(30):38916-38930. PubMed ID: 39041453
    [Abstract] [Full Text] [Related]

  • 8. Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy.
    Kim J, Santos OA, Park JH.
    J Control Release; 2014 Oct 10; 191():98-104. PubMed ID: 24892975
    [Abstract] [Full Text] [Related]

  • 9. Aluminum-chloride-phthalocyanine encapsulated in liposomes: activity against naturally occurring dog breast cancer cells.
    Rocha MS, Lucci CM, Longo JP, Galera PD, Simioni AR, Lacava ZG, Tedesco AC, Azevedo RB.
    J Biomed Nanotechnol; 2012 Apr 10; 8(2):251-7. PubMed ID: 22515076
    [Abstract] [Full Text] [Related]

  • 10. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C, Xu W, Wei Z, Ou C, Wu J, Tong J, Cai Y, Dong X, Han W.
    J Mater Chem B; 2020 Jan 28; 8(4):648-654. PubMed ID: 31898718
    [Abstract] [Full Text] [Related]

  • 11. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y, Zhou L, Shen Z, Ma Q, Zhao Y, Sun Y, Cao J.
    Drug Deliv; 2022 Dec 28; 29(1):238-253. PubMed ID: 35001784
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer.
    Ogbodu RO, Nitzsche B, Ma A, Atilla D, Gürek AG, Höpfner M.
    J Photochem Photobiol B; 2020 Jul 28; 208():111915. PubMed ID: 32480203
    [Abstract] [Full Text] [Related]

  • 13. Receptor-targeting phthalocyanine photosensitizer for improving antitumor photocytotoxicity.
    Xu P, Chen J, Chen Z, Zhou S, Hu P, Chen X, Huang M.
    PLoS One; 2012 Jul 28; 7(5):e37051. PubMed ID: 22693566
    [Abstract] [Full Text] [Related]

  • 14. Zn phthalocyanines loaded into liposomes: Characterization and enhanced performance of photodynamic activity on glioblastoma cells.
    Miretti M, Tempesti TC, Prucca CG, Baumgartner MT.
    Bioorg Med Chem; 2020 Apr 01; 28(7):115355. PubMed ID: 32067893
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells.
    Doustvandi MA, Mohammadnejad F, Mansoori B, Tajalli H, Mohammadi A, Mokhtarzadeh A, Baghbani E, Khaze V, Hajiasgharzadeh K, Moghaddam MM, Hamblin MR, Baradaran B.
    Photodiagnosis Photodyn Ther; 2019 Dec 01; 28():88-97. PubMed ID: 31454716
    [Abstract] [Full Text] [Related]

  • 16. Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting.
    Delahoussaye YM, Hay MP, Pruijn FB, Denny WA, Brown JM.
    Biochem Pharmacol; 2003 Jun 01; 65(11):1807-15. PubMed ID: 12781332
    [Abstract] [Full Text] [Related]

  • 17. Polymeric micelles encapsulating pH-responsive doxorubicin prodrug and glutathione-activated zinc(II) phthalocyanine for combined chemotherapy and photodynamic therapy.
    Gao D, Lo PC.
    J Control Release; 2018 Jul 28; 282():46-61. PubMed ID: 29673646
    [Abstract] [Full Text] [Related]

  • 18. A 2-pyridone modified zinc phthalocyanine with three-in-one multiple functions for photodynamic therapy.
    Li Y, Wang C, Zhou L, Wei S.
    Chem Commun (Camb); 2021 Mar 28; 57(25):3127-3130. PubMed ID: 33630986
    [Abstract] [Full Text] [Related]

  • 19. Cervical cancer cells (HeLa) response to photodynamic therapy using a zinc phthalocyanine photosensitizer.
    Hodgkinson N, Kruger CA, Mokwena M, Abrahamse H.
    J Photochem Photobiol B; 2017 Dec 28; 177():32-38. PubMed ID: 29045918
    [Abstract] [Full Text] [Related]

  • 20. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
    Huang L, Wei G, Sun X, Jiang Y, Huang Z, Huang Y, Shen Y, Xu X, Liao Y, Zhao C.
    Eur J Med Chem; 2018 May 10; 151():294-303. PubMed ID: 29627724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.